ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Bioink Based on the DECM for 3D-Bioprinting of Bionic Pancreas – First Results of Animal

M. Klak1, K. Kosowska1, T. Bryniarski1, I. Lojszczyk1, T. Dobrzanski2, G. Tymicki1, A. Filip1, A. A. Szczepankiewicz3, R. Olkowski4, A. Kosowska4, A. Berman1, A. Kaminski4, M. Wszola1

1Foundation of Research and Science Development, Warsaw, Poland, 2Polbionica LTD, Warsaw, Poland, 3Institute of Experimental Biology M. Nencki PAN, Warsaw, Poland, 4Medical University of Warsaw, Warsaw, Poland

Meeting: 2022 American Transplant Congress

Abstract number: 645

Keywords: Bioengineering, Islets, Mice, Pancreas

Topic: Basic Science » Basic Science » 06 - Tissue Engineering and Regenerative Medicine

Session Information

Session Name: Tissue Engineering and Regenerative Medicine

Session Type: Poster Abstract

Date: Saturday, June 4, 2022

Session Time: 5:30pm-7:00pm

 Presentation Time: 5:30pm-7:00pm

Location: Hynes Halls C & D

*Purpose: Tissue engineering is an interdisciplinary field involving activities based on two interrelated areas: developing new methods to repair, regenerate and replace damaged tissues and organs. Currently, the most suitable materials for bioprinting of living constructs are biomaterials based on decellularized extracellular matrix (ECM). In this researches, we made two independent hypotheses: (1) that bioinks based on ECM obtained from pancreatic organs should provide structural elements that improve the functionality of pancreatic islets in vitro and (2) the produced bioink should be biocompatible and safe for living organisms, which must be tested on animals.

*Methods: The bioinks used in this study were: 3% alginate, 3% alginate with the addition of gelatin, 3% alginate with the addition of proteins from the extracellular matrix of the pancreas, commercially available bioink with cellulose nanofibrils and our proprietary pancreatic dECM bioink. The islets were subjected to the bioprinting process in each of the above-mentioned bioinks. The petals and islets of the control group were then grown on the inserts immersed in the growth medium for 7 days. After the 7th day of testing, both the petals and the control islets were stained with FDA/Pi and GSIS to demonstrate their viability. Surface and transmission electron microscope was preformed. Bio ink was bioprinted and transplanted into BALB/c mice and observation period was one year.

*Results: There were no statistical difference in GSIS results after bioprinting procedure and control islets after 3Dbioprinting of islets. On the 7-th day post 3Dbioprinitng GSIS was significantly higher in islets bio-printed in our dECM bio-ink in comparison to control group and other bio-inks and was respectively in high glucose: 30 uU/ml vs 5 in control and 4 in other groups.

*Conclusions: The bio-ink produced by the authors allows for bioprinting of complex tissue systems together with pancreatic cells and islets, while improving their functionality by recreating the natural environment of the pancreas.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Klak M, Kosowska K, Bryniarski T, Lojszczyk I, Dobrzanski T, Tymicki G, Filip A, Szczepankiewicz AA, Olkowski R, Kosowska A, Berman A, Kaminski A, Wszola M. Bioink Based on the DECM for 3D-Bioprinting of Bionic Pancreas – First Results of Animal [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/bioink-based-on-the-decm-for-3d-bioprinting-of-bionic-pancreas-first-results-of-animal/. Accessed March 26, 2023.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2023 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences